Mirion Technologies, Inc.

Mirion Technologies, Inc. has a liquidity position that is moderate, with a current ratio of 3.19, indicating the company can cover its short-term obligations more than three times over. However, the company's net cash position is negative after subtracting total debt, and the diluted share count is significantly higher than the basic share count, signaling potential dilution risk. The company's cash and equivalents amount to $397.9 million, while its short-term debt is relatively low at $1.6 million. Profitability metrics for Mirion are weak, with a return on equity of -0.0018 and a return on assets of -0.001, both of which are below the industry median for industrial machinery and equipment firms. The company reported a net loss of $3.4 million in Q1 2026, down from a net income of $0.4 million in the same period the previous year. The gross profit margin stands at 46.2%, which is in line with the industry average, but the operating margin is only 1.4%, indicating high operating costs relative to revenue. Mirion's revenue is split between its Medical and Nuclear & Safety segments, with the Medical segment focusing on radiation therapy quality assurance and nuclear medicine. The Nuclear & Safety segment serves nuclear power plants and defense applications. The company's geographic exposure is not explicitly detailed in the provided data, but it operates globally, with products used in nuclear power plant construction, operation, and decommissioning. The company's growth trajectory is mixed. Revenue in Q1 2026 was $257.6 million, a slight increase from the previous year's $186.2 million in cash and equivalents. However, the net loss and weak operating income suggest challenges in maintaining profitability. The outlook for the current fiscal year indicates a continuation of these trends, with no significant improvement in the near term. Risk factors for Mirion include high dilution potential, as evidenced by the significant difference between basic and diluted share counts. The company's liquidity risk is moderate, but the negative net cash position after debt is a concern. The risk assessment also flags potential dilution from recent offerings or future capital-raising activities. The company's exposure to geopolitical factors, such as the conflict in the Middle East and U.S.-China relations, could impact its operations and supply chain. Recent events include the company's partial coverage in Companyfacts, with recent filings backfilling basic share data. The management discussion and analysis section of the financial reports highlight various operational and strategic considerations, including supply chain challenges, legal claims, and the impact of global conflicts. The company also notes the United Nations' declaration to triple nuclear energy capacity by 2050, which could present future market opportunities.